Snake venom hemagglutinin

蛇毒血凝酶

Report date: 2025/12/09 17:56:40

Base Information

Drug NameSnake venom hemagglutinin
Drug Alias Name蛇毒血凝酶注射液圆斑蝰蛇蛇毒血凝酶尖吻蝮蛇蛇毒血凝酶速乐涓Slounase
ClassificationNatural product/Extract > Animal extract
Mechanisms of ActionFibrinogen modulatorsBlood coagulation pathway activation
TargetsFibrinogen
Therapy Area/IndicationsHemorrhageHemorrhagic Disorders
Global Approved IndicationsHemorrhageHemorrhagic Disorders
Approved Indications in ChinaHemorrhageHemorrhagic Disorders
Original Approved Country/TerritoryMainland China
Original Approved Date2006/05/29
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLee'S Pharmaceutical (Hk) Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHemorrhageHemorrhagic Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksKEGG